SELLAS Life Sciences
SLS
#4136
Rank
HK$23.82 B
Marketcap
HK$121.16
Share price
24.70%
Change (1 day)
604.79%
Change (1 year)

Revenue for SELLAS Life Sciences (SLS)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SELLAS Life Sciences from 2007 to 2025

Annual revenue

Year Revenue Change
2025 N/A
2024 N/A
2023 N/A-100%
2022 HK$7.81 M-86.82%
2021 HK$59.26 M302.34%
2020 HK$14.72 M
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A-100%
2014 HK$59.71 M209.65%
2013 HK$19.28 M
2012 N/A
2011 N/A
2010 N/A
2009 N/A
2007 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA